Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (14) 14
oncology (12) 12
humans (11) 11
chemotherapy (9) 9
male (9) 9
aged (8) 8
bladder cancer (8) 8
cancer (7) 7
female (7) 7
middle aged (7) 7
aged, 80 and over (6) 6
clinical trials (6) 6
metastasis (6) 6
treatment outcome (6) 6
antineoplastic combined chemotherapy protocols - therapeutic use (5) 5
bladder-cancer (5) 5
carcinoma (5) 5
carcinoma, transitional cell - drug therapy (5) 5
cisplatin (5) 5
article (4) 4
care and treatment (4) 4
neoplasm metastasis (4) 4
urinary bladder neoplasms - drug therapy (4) 4
urologic neoplasms - drug therapy (4) 4
urothelial carcinoma (4) 4
abridged index medicus (3) 3
adult (3) 3
antineoplastic combined chemotherapy protocols - administration & dosage (3) 3
biomarkers (3) 3
cisplatin - administration & dosage (3) 3
cystectomy (3) 3
docetaxel (3) 3
drug administration schedule (3) 3
gemcitabine (3) 3
metastatic (3) 3
neoadjuvant chemotherapy (3) 3
neoadjuvant therapy - methods (3) 3
neoplasm invasiveness (3) 3
patients (3) 3
prostate cancer (3) 3
randomized-trial (3) 3
research (3) 3
survival (3) 3
tumors (3) 3
urothelial cancer (3) 3
abiraterone (2) 2
androstenes - administration & dosage (2) 2
antibodies, monoclonal - administration & dosage (2) 2
antibodies, monoclonal - therapeutic use (2) 2
antineoplastic agents - administration & dosage (2) 2
antineoplastic agents - adverse effects (2) 2
antineoplastic agents - therapeutic use (2) 2
antineoplastic combined chemotherapy protocols - adverse effects (2) 2
biomarkers, tumor - analysis (2) 2
cancer therapies (2) 2
carcinoma, transitional cell - chemistry (2) 2
carcinoma, transitional cell - pathology (2) 2
ctla-4 blockade (2) 2
disease-free survival (2) 2
double-blind (2) 2
doxorubicin (2) 2
enzalutamide (2) 2
gene expression (2) 2
granulocyte colony-stimulating factor - therapeutic use (2) 2
immunotherapy (2) 2
infusions, intravenous (2) 2
internal medicine (2) 2
kaplan-meier estimate (2) 2
ligands (2) 2
long-term-survival (2) 2
medical colleges (2) 2
medicine, general & internal (2) 2
men (2) 2
methotrexate (2) 2
mitoxantrone (2) 2
multicenter (2) 2
mutation (2) 2
neoplasm staging (2) 2
open-label (2) 2
pembrolizumab (2) 2
prospective studies (2) 2
prostatic neoplasms, castration-resistant - drug therapy (2) 2
protective agents - therapeutic use (2) 2
radical cystectomy (2) 2
response evaluation criteria in solid tumors (2) 2
safety (2) 2
single-arm (2) 2
survival analysis (2) 2
trends (2) 2
trial (2) 2
urinary bladder neoplasms - chemistry (2) 2
urinary bladder neoplasms - pathology (2) 2
urology & nephrology (2) 2
vinblastine (2) 2
27 hsp27 (1) 1
abiraterone acetate (1) 1
accuracy (1) 1
acquired-resistance (1) 1
active surveillance (1) 1
administration, intravenous (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Atezolizumab (atezo) in special populations: Analyses from an expanded access program (EAP) in platinum-treated locally advanced or metastatic urothelial carcinoma (mUC)
by Hoffman-Censits, Jean H and Pal, Sumanta K and Zheng, Hanzhe and Tayama, Darren and Bellmunt, Joaquim
Journal of Clinical Oncology, ISSN 0732-183X, 05/2018, Volume 36, Issue 15_suppl, pp. 4529 - 4529
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Atezolizumab (atezo) in platinum-treated locally advanced or metastatic urothelial carcinoma (mUC): Safety analysis from an expanded access study
by Bellmunt, Joaquim and Pal, Sumanta K and Zheng, Hanzhe and Tayama, Darren and Chang, Dannis and Hoffman-Censits, Jean H
Journal of Clinical Oncology, ISSN 0732-183X, 05/2017, Volume 35, Issue 15_suppl, pp. 4532 - 4532
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Long-term outcomes in elderly patients (pts) from IMvigor210: Atezolizumab (atezo) in metastatic urothelial cancer (mUC)
by Balar, Arjun Vasant and Dreicer, Robert and Loriot, Yohann and Perez-Gracia, Jose Luis and Hoffman-Censits, Jean H and Petrylak, Daniel Peter and Van Der Heijden, Michiel Simon and Shen, Xiaodong and Ding, Beiying and Ramirez-Montagut, Teresa and Rosenberg, Jonathan E
Journal of Clinical Oncology, ISSN 0732-183X, 03/2019, Volume 37, Issue 7_suppl, pp. 394 - 394
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Defects in DNA repair genes and long-term survival in cisplatin-based neoadjuvant chemotherapy for muscle invasive bladder cancer (MIBC)
by Miron, Benjamin and Ross, Eric A and Anari, Fern and O'Neill, John and Hoffman-Censits, Jean H and Zibelman, Matthew R and Kutikov, Alexander and Viterbo, Rosalia and Greenberg, Richard E and Chen, David and Lallas, Costas D and Trabulsi, Edouard John and Alpaugh, R. Katherine and Dulaimi, Essel and Golemis, Erica and Uzzo, Robert and Plimack, Elizabeth R
Journal of Clinical Oncology, ISSN 0732-183X, 05/2019, Volume 37, Issue 15_suppl, pp. 4536 - 4536
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text FGFR3 Driven Metastatic Urothelial Carcinoma of the Urinary Bladder (mUCB): A Comprehensive Genomic Profiling Study
by Ross, Jeffrey S and Gay, Laurie M and Ferry, Elizabeth Kate and Jacob, Joseph and Shapiro, Oleg and Hoffman-Censits, Jean H and Millis, Sherri Z and Elvin, Julia Andrea and Chung, Jon and Vergilio, Jo-Anne and Suh, James and Ramkissoon, Shakti H and Severson, Eric Allan and Daniel, Sugganth and Killian, Jonathan Keith and Ali, Siraj Mahamed and Schrock, Alexa Betzig and Miller, Vincent A and Bratslavsky, Gennady
Journal of Clinical Oncology, ISSN 0732-183X, 05/2018, Volume 36, Issue 15_suppl, pp. 4531 - 4531
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Can post-operative prostate fossa radiation be omitted in patients with high-risk features using a genomic classifier?
by Marascio, Joseph Anthony and Bloom, Matthew and Hurwitz, Mark and Gomella, Leonard G and Lallas, Costas D and Trabulsi, Edouard John and Mann, Mark and Mark, James Ryan and Calvaresi, Anne and Kelly, W. Kevin and Hoffman-Censits, Jean H and Godwin, James Luke and Dicker, Adam and Den, Robert Benjamin
Journal of Clinical Oncology, ISSN 0732-183X, 02/2018, Volume 36, Issue 6_suppl, pp. 101 - 101
101 Background: At our institution, based upon the AUA/ASTRO guidelines, discussion of adjuvant radiation therapy (ART) for patients with adverse pathologic... 
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text c15-162: Phase IB trial of radium 223 and niraparib in patients with castrate resistant prostate cancer (NiraRad)
by Godwin, James Luke and Hoffman-Censits, Jean H and Den, Robert Benjamin and Knudsen, Karen E and Schiewer, Matthew Joseph and Leiby, Benjamin E and Southwell, Traci and Hubert, Christine and Patnaik, Akash and Sonpavde, Guru and Sartor, A. Oliver and Yang, Eddy Shih-Hsin and Kelly, William Kevin and The Prostate Cancer Clinical Trials Consortium
Journal of Clinical Oncology, ISSN 0732-183X, 02/2018, Volume 36, Issue 6_suppl, pp. TPS385 - TPS385
TPS385 Background: PARP1 is a key regulator of the transition to lethal castrate resistant prostate cancer (CRPC); niraparib is a potent and selective PARP-1... 
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Subclonal mutational heterogeneity and survival in cisplatin-resistant muscle-invasive bladder cancer
by Liu, David and Abbosh, Philip and Keliher, Daniel and Reardon, Brendan and Mouw, Kent William and Taylor-Weiner, Amaro and Mullane, Stephanie Anne and Han, Garam and Teo, MinYuen and Kim, Jaegil and Al-Ahmadie, Hikmat and Iyer, Gopa and Dulaimi, Essel and Chen, David and Hoffman-Censits, Jean H and Carter, Scott L and Bellmunt, Joaquim and Plimack, Elizabeth R and Rosenberg, Jonathan E and Van Allen, Eliezer Mendel
Journal of Clinical Oncology, ISSN 0732-183X, 05/2017, Volume 35, Issue 15_suppl, pp. 4512 - 4512
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text A phase I/II study of the investigational drug alisertib in combination with abiraterone and prednisone for patientswithmetastatic castration-resistant prostate cancer progressing on abiraterone
by Lin, Jianqing and Patel, Sheel A and Sama, Ashwin R and Hoffman-Censits, Jean H and Kennedy, Brooke and Kilpatrick, Deborah and Ye, Zhong and Yang, Hushan and Mu, Zhaomei and Leiby, Benjamin and Lewis, Nancy and Cristofanilli, Massimo and Kelly, William Kevin
Oncologist, ISSN 1083-7159, 11/2016, Volume 21, Issue 11, pp. 1296 - 1297
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Genomic evolution in muscle-invasive bladder cancer resistant to neoadjuvant chemotherapy
by Liu, David and Abbosh, Philip and Miao, Diana and Boyd, Mariel Elena and Hoffman-Censits, Jean H and Iyer, Gopa and Tolaney, Sara M and Mouw, Kent William and Carter, Scott L and Bellmunt, Joaquim and Plimack, Elizabeth R and Rosenberg, Jonathan E and Van Allen, Eliezer Mendel
Journal of Clinical Oncology, ISSN 0732-183X, 05/2016, Volume 34, Issue 15_suppl, pp. 4518 - 4518
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Comprehensive genomic profiling of neuroendocrine carcinoma of the prostate
by Pal, Sumanta K and Milowsky, Matthew I and Elvin, Julia Andrea and Ali, Siraj Mahamed and Hoffman-Censits, Jean H and Vergilio, Jo-Anne and Suh, James and Mian, Badar and Fisher, Hugh A.G and Nazeer, Tipu and Miller, Vincent A and Stephens, Philip J and Ross, Jeffrey S
Journal of Clinical Oncology, ISSN 0732-183X, 01/2016, Volume 34, Issue 2_suppl, pp. 187 - 187
187 Background: Neuroendocrine carcinoma of the prostate (NCAP) is an aggressive high grade malignancy that often presents as metastatic disease. Current... 
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Efficacy of BGJ398, a fibroblast growth factor receptor 1–3 inhibitor, in patients with previously treated advanced urothelial carcinoma with FGFR3 alterations
by Pal, Sumanta K and Rosenberg, Jonathan E and Hoffman-Censits, Jean H and Berger, Raanan and Quinn, David I and Galsky, Matthew D and Wolf, Juergen and Dittrich, Christian and Keam, Bhumsuk and Delord, Jean-Pierre and Schellens, Jan H. M and Gravis, Gwenaelle and Medioni, Jacques and Maroto, Pablo and Sriuranpong, Virote and Charoentum, Chaiyut and Burris, Howard A and Grünwald, Viktor and Petrylak, Daniel and Vaishampayan, Ulka and Gez, Eliahu and de Giorgi, Ugo and Lee, Jae-Lyun and Voortman, Jens and Gupta, Sumati and Sharma, Sunil and Mortazavi, Amir and Vaughn, David J and Isaacs, Randi and Parker, Katie and Chen, Xueying and Yu, Kun and Porter, Dale and Porta, Diana Graus and Bajorin, Dean F
Cancer discovery, ISSN 2159-8274, 2018, Volume 8, Issue 7, pp. 812 - 821
BGJ398, a potent and selective pan-FGFR antagonist, was prospectively evaluated in patients with metastatic urothelial carcinoma bearing a diverse array of... 
b_open_article_in_toll_access_journal
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text An exploratory study to investigate the immunomodulatory activity of radiation therapy in combination with pembrolizumab in patients with renal cell cancer
by Lin, Jianqing and Hoffman-Censits, Jean H and Kelly, William Kevin and Tuluc, Madalina and Shaw, Colette and Philipose, Sherin and Leiby, Benjamin E and Louie, Jennifer and Harshyne, Larry and Kean, Rhonda and Bar-Ad, Voichita and Den, Robert Benjamin and Hurwitz, Mark and Johnson, Jennifer Maria and Hubert, Christine and Deshmukh, Sandeep and Dicker, Adam and Hooper, D. Craig and Lu, Bo
Journal of Clinical Oncology, ISSN 0732-183X, 05/2017, Volume 35, Issue 15_suppl, pp. e16058 - e16058
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text c15-153: Randomized phase IB/II study of enzalutamide with and without ribociclib in patients with metastatic castrate resistant, chemotherapy naïve prostate cancer that retains RB expression
by Kelly, William Kevin and Godwin, James Luke and Hoffman-Censits, Jean H and Knudsen, Karen E and De Leeuw, Renee and Leiby, Benjamin E and Southwell, Traci and Hubert, Christine and Smith, David C and Chatta, Gurkamal S and Aghalar, Jahan and Scher, Howard I and Bose, Rohit and Autio, Karen A and Abida, Wassim and Slovin, Susan F and The Prostate Cancer Clinical Trials Consortium
Journal of Clinical Oncology, ISSN 0732-183X, 02/2018, Volume 36, Issue 6_suppl, pp. TPS384 - TPS384
TPS384 Background: Current data suggests RB function is often attenuated in tumors through hyperphosphorylation; thus, RB activity can be “re-awakened” in RB+... 
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text ECOG 8141: A prospective phase II trial of neoadjuvant systemic chemotherapy followed by extirpative surgery for patients with high grade upper tract urothelial carcinoma
by Hoffman-Censits, Jean H and Margulis, Vitaly and Hahn, Noah M and Trabulsi, Edouard John and Beaver, Allison and Plimack, Elizabeth R
Journal of Clinical Oncology, ISSN 0732-183X, 05/2016, Volume 34, Issue 15_suppl, pp. TPS4585 - TPS4585
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Full Text Evaluating the effect of therapy duration on survival in patients with metastatic castration-resistant prostate cancer receiving radium-223
by Williams, Noelle L and Nowak-Choi, Kamila and Skowronski, Jenna and Dan, Tu and Eldredge, Harriet Belding and Hoffman-Censits, Jean H and Lin, Jianqing and Kelly, William Kevin and Gomella, Leonard G and Lallas, Costas D and Trabulsi, Edouard John and Hurwitz, Mark and Dicker, Adam and Leiby, Benjamin E and Dabbish, Nooreen and Den, Robert B
Journal of Clinical Oncology, ISSN 0732-183X, 02/2017, Volume 35, Issue 6_suppl, pp. e593 - e593
e593 Background: The use of radium-223 in patients with metastatic castration-resistant prostate cancer (mCRPC) improves overall survival (OS) and quality of... 
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
17. Full Text An exploratory study to investigate the immunomodulatory activity of radiation therapy in combination with pembrolizumab in patients with renal cell cancer
by Lin, Jianqing and Hoffman-Censits, Jean H and Kelly, William Kevin and Tuluc, Madalina and Shaw, Colette and Louie, Jennifer and Harshyne, Larry and Kean, Rhonda and Bar-Ad, Voichita and Den, Robert B and Hurwitz, Mark and Johnson, Jennifer Maria and Hubert, Christine and Philipose, Sherin and Leiby, Benjamin E and Deshmukh, Sandeep P and Dicker, Adam and Hooper, D. Craig and Lu, Bo
Journal of Clinical Oncology, ISSN 0732-183X, 02/2017, Volume 35, Issue 6_suppl, pp. 518 - 518
518 Background: Preclinical data suggest there are synergistic effects of radiation therapy (RT) and check point inhibitors in anticancer immunity. The primary... 
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
18. Full Text Comprehensive genomic profiling of relapsed and refractory small cell neuroendocrine carcinoma of the urinary bladder
by Pal, Sumanta K and Hoffman-Censits, Jean H and Elvin, Julia Andrea and Vergilio, Jo-Anne and Suh, James and Ramkissoon, Shakti and Ali, Siraj Mahamed and Schrock, Alexa Betzig and Fisher, Hugh A.G and Mian, Badar and Nazeer, Tipu and Fabrizio, David and Frampton, Garrett Michael and Stephens, Phil and Miller, Vincent A and Gay, Laurie M and Ross, Jeffrey S
Journal of Clinical Oncology, ISSN 0732-183X, 02/2017, Volume 35, Issue 6_suppl, pp. 350 - 350
350 Background: Small cell neuroendocrine carcinoma of the bladder (SCCB) is rare but aggressive form of genitourinary cancer that can arise de novo or in... 
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
19. Full Text HCRN GU14-188: Neoadjuvant pembrolizumab (P) and gemcitabine (G) with or without cisplatin (C) in muscle invasive urothelial cancer (MIUC)
by Hoimes, Christopher J and Abouassaly, Robert and Saltzman, Joel N and Fleming, Mark T and Hoffman-Censits, Jean H and Byrd, Tara and Eitman, Cheryl and Snyder-Willis, Michele and O'Neill, Jodi and Wood, Lisa and Elliott, Robin and Cooney, Matthew M
Journal of Clinical Oncology, ISSN 0732-183X, 05/2016, Volume 34, Issue 15_suppl, pp. TPS4578 - TPS4578
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
20. Full Text Updated efficacy and > 1-y follow up from IMvigor210: Atezolizumab (atezo) in platinum (plat) treated locally advanced/metastatic urothelial carcinoma (mUC)
by Dreicer, Robert and Hoffman-Censits, Jean H and Flaig, Thomas W and Grande, Enrique and Balmanoukian, Ani Sarkis and von Amsberg, Gunhild and Theodore, Christine and Chowdhury, Simon and Bracarda, Sergio and Clement, Jessica Mary and Yu, Evan Y and Rezazadeh Kalebasty, Arash and Niegisch, Guenter and Culine, Stephane and Gordon, Michael S and Cui, Na and Mariathasan, Sanjeev and Legrand, Fatema A and Abidoye, Oyewale O and Petrylak, Daniel Peter
Journal of Clinical Oncology, ISSN 0732-183X, 05/2016, Volume 34, Issue 15_suppl, pp. 4515 - 4515
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.